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ABSRACT
OBJECTIVE: The objective of this selective evidence based medicine (EBM) review is to
determine whether or not “Is pain intensity reduced by the application of kinesio tape in
postmenopausal women with mild to moderate venous insufficiency?”
STUDY DESIGN: A systemic review compiling data from three randomized controlled trials
between 2013 and 2014, all in the English language.
DATA SOURCES: Three pertinent studies evaluating the reduction of pain intensity in
postmenopausal women with mild to moderate chronic venous insufficiency were included in
this review. Sources were selected using PubMed and Cochrane Library.
OUTCOME(S) MEASURED: Patient perception of pain using a Visual Analog Scale (VAS) of
0-10.
RESULTS: Within group comparisons demonstrated a statistically significant difference in pain
amongst the group receiving kinesio tape intervention. Aguilar-Ferrandiz et al. 2014a found the
increase in VAS score was 3.12 (2.61, 3.63) for the experimental group and 0.37 (0.16, 0.59) for
the control group with a 95% CI, p=0.016 (Clin Rehabil. 2014a; 28(1):69-81. doi:
10.1177/0269215512469120). A Cohen’s d score of 1.73 for the experimental and 0.17 for the
control group, indicates a greater reduction in pain intensity in the experimental group (AguilarFerrandiz ME, Castro-Sanchez AM, Mataran-Penarrocha GA, et al. Clin Rehabil. 2014a;
28(1):69-81.doi: 10.1177/0269215512469120). The Aguilar-Ferrandiz et al. 2013 study reported
an increase in VAS of 2.10 (1.90-2.50) in the experimental group and 0.32 (0.07 -0.57) in the
control group with a 95% CI, p=0.003 (Arch Phys Med Rehabil. 2013; 94(12):2315-2328.
doi:10.1016/j.apmr.2013.05.016). In Aguilar Ferrandiz 2014b the increase in VAS score of the
experimental group was 2.79 (2.16, 3.41) with a 95% CI, p=0.001 (Arch Phys Med Rehabil.
2014b; 95(7):1229-1239. doi:10.1016/j.apmr.2014.03.024). The increase in VAS score for the
control group was 0.25 (0.02, 0.48) with a CI 95%, p=0.036 (Aguilar-Ferrándiz ME, MorenoLorenzo C, Matarán-Peñarrocha GA, et al. Arch Phys Med Rehabil.2014b; 95(7):1229-1239. doi:
10.1016/j.apmr.2014.03.024). Cohen’s d score for the experimental group was 1.470 and the
control was 0.115, indicating that there was a significant difference with treatment over time in
the experimental group, but little change for the control group (Aguilar-Ferrándiz ME, MorenoLorenzo C, Matarán-Peñarrocha GA, et al. Arch Phys Med Rehabil. 2014b; 95(7):1229-1239.
doi: 10.1016/j.apmr.2014.03.024).
CONCLUSIONS: The evidence presented in this review demonstrates that kinesio tape (KT) is
an effective treatment option to reduce pain intensity in postmenopausal women with mild to
moderate chronic venous insufficiency, however the impact of visual colors and proprioceptive
cutaneous afferents from the KT may have a placebo effect.
KEYWORDS: Kinesio, tape, randomized control trial, postmenopausal
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INTRODUCTION
Chronic venous insufficiency (CVI) is a condition that worsens with age. It is
characterized by venous hypertension in the lower extremities and venous reflux, which occurs
when the valves in the veins do not function properly, leading to reversal of blood flow through
the valves.1 The increase in pressure from the incompetent valves and resulting thrombosis
destroy the valves.1 Deep and superficial veins become distended from excess volume, further
distorting venous vessel walls, leading to further venous dilation and valve incompetence.1 As a
result of this inflammation, increased expression of proteinases by the vessel cells breaks down
the extracellular matrix and leads to further abnormal vascular permeability and edema.2 Regular
contractions of the gastrocnemius muscle contribute to venous return, therefore lack of exercise
can lead to CVI.3-5 CVI presentation can include pain, leg heaviness, muscle cramps, itching,
dilated veins, edema, lipodermatosclerosis, brown skin hyperpigmentation or ulceration of the
lower limbs.3-5
CVI affects greater than 30 million adults in the U.S., with 17% prevalence in men and
40% in women.2 The incidence of CVI is highest in western countries and is expected to rise as
the population ages and obesity becomes more common. As Americans live longer, the number
of patients with CVI will increase.2 In 2006 there were six million outpatient visits for CVI in the
U.S. and this number is projected to grow.6 CVI consumes 2% of the healthcare budget, with the
direct medical cost of CVI in the U.S. estimated to be three billion dollars annually.2
Postmenopausal women have a high predisposition to CVI because of a combination of various
risk factors, including age, gender, family history of venous disease, sedentary life style, obesity,
lower extremity trauma, prolonged standing, and multiple pregnancies.3
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The severity of venous disease can be classified using the C0-C6 CEAP scoring system
which is made up of four clinical components: (C) clinical signs, (E) etiology, (A) anatomy and
(P) pathophysiology.6 The classification system includes C0 (no visible or palpable signs of
venous disease), C1 (telangiectasia or reticular veins), C2 (varicose veins, diameter >3mm), C3
(edema without skin changes), C4 (skin changes ascribed to venous disease- pigmentation,
venous eczema, lipodermatosclerosis), C5 (healed venous ulcer) or C6 (active venous ulcer).4,6
For the purpose of this review mild to moderate CVI was classified as C1-C3.
Current noninvasive methods for the treatment of CVI are leg elevation, exercise, and
compression therapy (compression stockings 20-30 mmhg), which reduce vein caliber and
improve venous hemodynamics by increasing venous return, improving lymphatic flow and
cutaneous microcirculation.2 Additionally, it is recommended that individuals implement a
healthy lifestyle and decrease their BMI, if necessary, to maintain an ideal body weight. Invasive
management includes vein ablation methods involving surgical excision, sclerotherapy, or
thermal ablation.2 Venous stenting and reconstruction are procedures offered for treatment based
upon extreme severity and poor prior response to medical therapy.2 Not everyone is a candidate
for an invasive procedure or surgery, and there is risk for infection. While leg elevation, exercise,
and compression stockings may be the primary management for CVI, or an adjunct to medical
therapy, there are often poor compliance rates of up to 33% especially in the presence of pain,
exudates, skin irritation, aesthetic reasons, discomfort, and difficulty putting on the stockings.5
Kinesio tape (KT) is a bandaging technique used to increase lymphatic and vascular flow, and
decrease pain. 3,5 The thin composure and elasticity of the KT produces less mechanical restraint
and allows for greater mobility as compared with conventional bandages, thus, KT may be used
as an alternative method for maximal treatment adherence and reduction of pain intensity in CVI.
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OBJECTIVE
The objective of this selective evidence based medicine (EBM) review is to determine
whether or not “Is pain intensity reduced by the application of kinesio tape in postmenopausal
women with mild to moderate venous insufficiency?”
METHODS
The EBM review evaluates three double-blinded randomized controlled trials. The
population of interest included postmenopausal women 50-75 years of age with mild to moderate
CVI. The demographics of the included studies are listed in Table 1. KT application was used as
an intervention in all three studies, with the control group, or placebo group, using a sham KT
protocol. The outcomes measured in all three studies included pain intensity at baseline and after
four weeks of treatment.
A detailed literature search using Pubmed and Cochrane Library was performed. The
initial search terms “kinesio tape” , “chronic venous insufficiency” , “randomized control trial”
and “postmenopausal” were used with appropriate search limits of a publish date after 2009 to
identify relevant clinical studies of KT in CVI. The articles were selected based on patient
oriented outcomes (POEMS) and relevance to the clinical question. The articles were written in
English and published in peer reviewed journals. The inclusion criteria when searching for
articles included full-text, randomized control trial, published within the last 10 years, and
postmenopausal women. Exclusion criteria included articles published before 2009, studies about
animals and non-post-menopausal women. The statistics reported included p values, Cohen d
scores and F-scores.
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Table 1 - Demographics & Characteristics of included studies
Study
AguilarFerrandiz3

RCT

#
Pts
120

Age
(yrs)
5075

RCT

123

RCT

130

Type

Exclusion Criteria

Post-menopausal
women, mild to
moderate CVI
(grades C1telangiectasies or
reticular veins, C2varicose veins, and
C3- edema)
classified using the
CEAP scale

Severe CVI (>grade C3),
arterial disorders,
plethysmographic signs of
venous thrombotic
obstruction, cardiorespiratory
disease, and contraindications
to KT technique: thrombosis,
wounds, severe trauma,
generalized edema secondary
to heart or renal problems,
carcinomas, intolerability or
allergy to KT tape and
pregnancy

5075

Post-menopausal
women mild to
moderate CVI
(grades C1telangiectasies or
reticular veins, C2varicose veins, and
C3- edema)
classified using the
CEAP scale

Severe CVI (>grade C3),
arterial disorders,
cardiorespiratory disease, and
contraindications to KT
technique: thrombosis,
wounds, severe trauma,
generalized edema secondary
to heart or renal disease,
cancer, intolerability or
allergy to KT and pregnancy

9

Standardized KT
application for
external
gastrocnemius

5075

Post-menopausal
women mild to
moderate CVI
(grades C1telangiectasies or
reticular veins, C2varicose veins, and
C3- edema)
classified using the
CEAP scale

CVI > grade C3, arterial
disorders, cardiorespiratory
disease, and contraindications
to KT: thrombosis, wounds,
severe trauma, edema
secondary to heart or kidney
disease, carcinoma,
intolerability, or allergy to
KT, and pregnancy

12

KT compression
treatment
following KT
recommendation
for
gastrocnemius
muscle

(2014a)

AgularFerrandiz4
(2013)

AguilarFerrandiz5
(2014b)

W
/D
16

Inclusion Criteria

Interventions
Standardized KT
for
gastrocnemius
muscle
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OUTCOMES MEASURED
All three studies measured pain intensity using a 10-cm visual analog scale (VAS)
ranging from 0 (no pain) to 10 (unbearable pain) as self-reported by the patient. Pain intensity
was measured at baseline and three times a week during a four week period for all three patient
oriented studies.
RESULTS
All three studies conducted were double-blinded randomized controlled trials, performed
in Spain as outpatient interventions.3-5 In each study a vascular therapist collected patient data on
age, body mass index, etiology, time since CVI onset, disability, predisposing factors, and
pretreatment disease status. 3-5 The therapist classified patients as CEAP score C1-C3, based on
criteria by the American Venous Forum committee.3-5 In order to make the classification, the
patients were examined in sitting and standing positions and peripheral pulse was felt by
palpation.3-5 Demographics and inclusion and exclusion criteria of participants are included in
Table 1. Treatment allocation for each study was concealed and computer software was used to
allocate each participant with a randomization code.3-5 All treatments were performed by a KT
instructor with clinical experience who was blinded to outcome measure and baseline
examination. The taping procedure used in the experimental and control groups was similar in all
three studies. The experimental group received taping with three strips each of 5 cm x 5 m
Kinesio Tex Gold following Kase guidelines.3-5 Two strips arranged in a Y shape were applied to
the medial gastrocnemius and the lateral gastrocnemius muscle to enhance gastrocnemius muscle
activation.3-5 For application, participants were in a prone position with tape tension ranging
from 15% to 50% from the tape origin to insertion site. 3-5 Next, an I-stripe was placed in the
supine position at maximum dorsiflexion and applied with 50% tension. 3-5 An additional two
pieces of tape were placed with 50% tension at the malleolar level to exert peripheral venous
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compression.3-5 The placebo group received an identical number of strips of sham tape, except
application was without tension and Kinesio taping guidelines were not followed. Despite
differences tape application was similar in appearance. Compliance in all three studies was based
on patient treatment intervention being performed three times a week during the four week
period. In each of the three studies assessed in this EBM review, data was presented as
continuous and could not be converted into dichotomous form within the studies.
In Aguilar Ferrandiz 2014a et al., 130 women were screened and 120 met the selection
criteria and were randomized into an experimental group which received KT application (n=60),
or to a placebo-control group which received a sham protocol (n=60). In the experimental and
control group, ten and six participants respectively did not receive the allocated intervention.3
The study followed the intention-to-treat analysis and subjects were analyzed as randomized and
no comment was made regarding worse case analysis of lost subjects.
Researchers used a mean change from baseline, four weeks post treatment and a 95% CI
for within and between-group change scores for pain in both experimental and control groups
based on VAS.3 There was a significantly lower score in the experimental group compared to the
control group for VAS (F = 23.94; p = 0.001) scores.3 Table 2 shows that while both the
experimental and control groups started with relatively equal baseline VAS scores, (experimental
5.63, control 5.28), four weeks post treatment the experimental group reported VAS scores of
2.51± 1.54 (95%CI) while the control group reported VAS scores of 4.91±1.99 (95%CI).3
Higher scores represent higher levels of pain. Within group, the experimental group showed a
Cohen d of 1.73, which is a large change over time, while the control group showed a Cohen d of
0.17, which is a very small change.3 The improvement in pain scores (Table 2) between before
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and after treatment was significantly greater in the experimental group (VAS 3.12) than in the
control group (VAS 0.37).3
Table 2: Kinesio Tape vs control: Change in pain intensity in Aguilar-Ferrandiz et al.
2014a3
Four
BetweenVAS (0Baseline
weeks
Within-group
Cohen’s d
group score
p
10)
pain
post
score change
change
treatment
-2.40
KT group 5.63±2.07 2.51±1.54
1.73
3.12(2.61,3.63)
(-3.09,0.016
1.70)
Control
5.28±2.36 4.91±1.99
0.17
0.37(0.16,0.59)
group
The Aguilar-Ferrandiz et al. 2013 study was a double-blind, randomized controlled trial
with concealed allocation. In this study, 160 women were screened and 123 met study selection
criteria based on demographics shown in Table 1. The 123 participants were randomly assigned
to an experimental group which received KT application (n= 62) or a placebo-control group
which received a sham KT application (n= 61).4 Nine participants were lost to follow-up, six
were from the experimental group and three from the control group.4 Lost subjects were still
included in the intention to treat analysis and no comment was made within the study regarding
worse case analysis of lost subjects. Table 3 shows baseline VAS scores of experimental, 5.7 and
control 5.6. Four weeks post treatment the experimental group reported VAS scores of 3.6 (95%
CI), while the control group reported VAS scores of 5.3 (95%CI).4 Within the experimental
group, this represents a change of 2.10, with a 95% CI, which is consistent with a clinically
worthwhile effect of 2.0.4 Therefore, there is a significant decrease in pain in the experimental
group, but not in the control group (within group change over four weeks 0.32).4 Even so, the
improvement in the experimental group is relatively low (at 2.0), given the VAS range of 0-10.4
Table 3 shows the between group score change four weeks post treatment is -1.74 (95% CI -2.3-

Ortiz Chavez, KT for Reduction of CVI Pain 8

1.15) which is a significant difference in VAS scores between the experimental and control
groups (p=0.003).4
Table 3: Kinesio Tape vs control: Change in pain intensity in Aguilar-Ferrandiz et al. 20134
BetweenFour weeks
Within-group
VAS (0-10)
Baseline pain
group score
p
post treatment score change
change
2.10(1.90 to
-1.74(-2.30 to
KT group
5.7±2.10
3.6±1.4
0.003
2.50)
-1.15)
Control
0.32(0.07 to
5.6±2.30
5.3±1.8
group
0.57)
The Aguilar-Ferrandiz et al. 2014b was double-blind, randomized controlled trial. In this
study, 170 women were screened and 130 met study selection criteria based on demographics
shown in Tale 1. The 130 participants were randomly assigned to an experimental group, which
received KT application (n= 65) or a placebo-control group, which received a sham-KT
treatment (n= 65).5 Twelve participants were lost to follow-up, five were from the experimental
group and seven participants from the control group. Lost participants were included in the
intention to treat analysis and no comment was made within the study regarding worse case
analysis of lost subjects. The study effect size was calculated according to Cohen’s d statistic,
for the experimental and control group, respectively, 1.470 and 0.115, as indicated in Table 4.5 A
Cohen d score ≥0.80 is considered a large difference and a score <0.20 is a negligible difference,
thus pain was reduced with greater intensity in the experimental group when compared to the
control.5 Table 4 shows that the results of the Aguilar-Ferrandiz et al. 2014b also showed a
between groups significant difference four weeks post treatment (F=62.31, p=0.001). Within
group comparisons demonstrated significant differences between baseline (5.58) and four weeks
post treatment (2.79, 95% CI) for VAS (p=0.001) in the experimental group, and for the control
group (baseline 5.29, four weeks post treatment 5.03, 95% CI) (p=0.036).5 Even though both
groups showed a reduction in pain, the improvement in pain was significantly greater in the
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experimental group, as shown by the between group change over four weeks of 2.25 (1.49-3.01,
95% CI) and p=0.001.5
Table 4: Kinesio Tape vs control: Change in pain intensity in Aguilar-Ferrandiz et al.
2014b5
Four
VAS (0Baseline
Cohen’s
Within-group
Between-group Withinweeks post
10)
pain
d
score change
score change
Group p
treatment
KT
5.58±2.09 2.79±1.67
1.470 2.79±(2.16,3.41) 2.25(1.49,3.01)
0.001
group
Control
5.29±2.33 5.03±2.17
0.115 0.25±(0.02,0.48)
0.036
group
No adverse events occurred as a result of KT or sham tape application in any of the three
studies. Intervention assigned to each group within the studies was well tolerated by participants.
DISSCUSSION
The number of patients diagnosed with CVI is increasing and although non-invasive
treatments, such as leg elevation, compression stockings and exercise, are commonly
implemented, a more adherent option is desired. KT can be rapidly applied, is air permeable and
water resistant, and can be worn during exercise, characteristics that can help increase
compliance with therapy in comparison to other compression systems.3 The three studies showed
a more statistically significant decrease in pain intensity in postmenopausal women with CVI
after four weeks of standardized KT treatment in comparison to the placebo groups.3-5 No
outliers were addressed in any of the three studies.
Pain levels were also positively affected in the placebo group, suggesting there may be a
placebo effect on pain. The placebo groups in all three studies experienced post treatment
improvement in pain intensity, although the reduction in pain intensity was smaller than in the
experimental groups.3-5 The input of visual KT colors and proprioceptive cutaneous afferents
may produce a belief that the tape provides a positive therapeutic effect on CVI, improving
perception of stability, confidence, and reassurance.3-5
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This review studied the effects of KT on pain intensity in CVI, but KT and pain reduction
has been studied in numerous different clinical scenarios. Abolhasani et al. 2019 showed KT as
having a positive effect for reducing pain in patients with osteoarthritis of the knee.7 Shakeri et
al. 2018 reported a significant decrease in pain intensity by application of KT in patients with
lateral epicondylitis and myofascial trigger point in forearm muscles.8 Aghapour et al. 2017
showed statistically significant reduction in pain and improved functional performance of the
vastus medialis oblique and quadriceps muscle in athletes with patellofemoral pain syndrome.9
These are a few notable studies that have reported positive effects from KT in reduction of pain
intensity in other areas of the body.
There is currently no research of long term effects of KT on skin, thus it could potentially
be a limitation in clinical application.3 KT is relatively inexpensive, although multiple
applications over a longer period can become costly. One roll of KT tape costs between $12-$17,
multipack of up to 6 count cost $65. KT application is currently not covered by insurance and
has not been proposed as a stand-alone intervention for CVI.
The participants in all three studies analyzed here were 50-75 year old postmenopausal
women, therefore results cannot be generalized to premenopausal women or men. Studies that
include both genders would be beneficial because although there is a higher incidence of CVI in
older women as compared to men, CVI is known to occur at earlier ages and in both genders. A
four week treatment period could be considered another limitation. These issues can be
overcome in future studies by application of KT over a longer time period and studying a more
generalized population. Another confounding factor could be an individual’s perception of pain,
which can be subjective and involves physical and psychological factors. All studies used a VAS
scale, which depends on patient honesty of pain intensity felt. Some individuals are more tolerant

Ortiz Chavez, KT for Reduction of CVI Pain 11

of pain than others. Further studies with a more in depth patient history and a standardized scale
for pain can ensure more reliable results.
CONCLUSION
Based on the three randomized control trials, there is satisfactory data to conclude that
pain intensity is reduced by the application of KT in postmenopausal women with mild to
moderate CVI.3-5 Future studies are warranted to compare the shape, direction and tensile force
of KT over muscle to determine optimal KT application techniques for pain reduction.
The effectiveness of KT as adjunctive therapy with physiotherapy treatments should also
be considered.3-5 A consistent inclusion and exclusion criteria was included among all three
studies, however future studies may benefit from a more standardized history and physical
analysis of the patient. Family history of varicose veins and blood clots, previous leg injuries,
and environmental and behavioral factors, such as prolonged standing or sitting posture at work,
can be taken into consideration when determining a sample group. Finally, although all
participants in the experimental groups showed a significant reduction of pain in all studies, all
control groups also showed decreased pain, although not as significant a decrease. This indicates
there is most likely a placebo effect from any kind of taping or treatment used in the controls and
this placebo effect likely decreases pain in conjunction with the decrease resulting from KT.
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